United Parcel Service is spending $48 million on 27 temperature-controlled facilities as part of a strategic push into the healthcare sector, a key growth category offering wider profit margins. The investment targets increasing demand for medications requiring cold-chain delivery, notably including GLP-1 weight-loss drugs. This move aligns with UPS's broader turnaround effort to modernize operations and shift toward higher-margin customers, even as overall revenue has declined. Management expects the second half of 2026 to be an inflection point for the overhaul, with early signs of success seen in rising U.S. revenue per package.
United Parcel Service IncInvestment in cold-chain facilities targets growing demand for GLP-1 drugs and other temperature-sensitive medications.